These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 20805202)

  • 1. Governments, pay for smoking cessation.
    Penz ED; Manns BJ; Hébert PC; Stanbrook MB
    CMAJ; 2010 Dec; 182(18):E810. PubMed ID: 20805202
    [No Abstract]   [Full Text] [Related]  

  • 2. Governments, pay for smoking cessation.
    Temple NJ
    CMAJ; 2010 Nov; 182(16):1761-2. PubMed ID: 21059783
    [No Abstract]   [Full Text] [Related]  

  • 3. Tobacco settlement dollars a "burning issue" for TMA.
    Williams B
    Tenn Med; 2000 Apr; 93(4):125-7. PubMed ID: 10754801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco control program saves california billions.
    Rowan K
    J Natl Cancer Inst; 2008 Oct; 100(20):1426-7. PubMed ID: 18840810
    [No Abstract]   [Full Text] [Related]  

  • 5. Why we need tobacco sales data for good tobacco control.
    Gartner CE; Chapman SF; Hall WD; Wakefield MA
    Med J Aust; 2010 Jan; 192(1):3-4. PubMed ID: 20047537
    [No Abstract]   [Full Text] [Related]  

  • 6. Value to smokers of improved cessation products: evidence from a willingness-to-pay survey.
    Busch S; Falba T; Duchovny N; Jofre-Bonet M; O'Malley S; Sindelar J
    Nicotine Tob Res; 2004 Aug; 6(4):631-9. PubMed ID: 15370159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health insurance coverage for smoking cessation services.
    Schauffler HH; Parkinson MD
    Health Educ Q; 1993; 20(2):185-206. PubMed ID: 8491632
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EU brings in new tobacco rules to deter young smokers.
    Watson R
    BMJ; 2014 Mar; 348():g1895. PubMed ID: 24589431
    [No Abstract]   [Full Text] [Related]  

  • 9. Biennial lung cancer screening in Canada with smoking cessation-outcomes and cost-effectiveness.
    Goffin JR; Flanagan WM; Miller AB; Fitzgerald NR; Memon S; Wolfson MC; Evans WK
    Lung Cancer; 2016 Nov; 101():98-103. PubMed ID: 27794416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expert ranking of tobacco control interventions for health economic modelling research in New Zealand.
    Wilson N; van der Deen FS; Pearson AL; Cobiac L; Blakely T
    N Z Med J; 2012 Jan; 126(1368):93-6. PubMed ID: 23385843
    [No Abstract]   [Full Text] [Related]  

  • 11. Should managed care organizations pay for nicotine replacement therapy?
    Westman EC
    Am J Manag Care; 1997 Feb; 3(2):335-7. PubMed ID: 10169267
    [No Abstract]   [Full Text] [Related]  

  • 12. A cost-benefit analysis of smoking cessation programs during the first trimester of pregnancy for the prevention of low birthweight.
    Hueston WJ; Mainous AG; Farrell JB
    J Fam Pract; 1994 Oct; 39(4):353-7. PubMed ID: 7931114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. If you try to stop smoking, should we pay for it? The cost-utility of reimbursing smoking cessation support in the Netherlands.
    Vemer P; Rutten-van Mölken MP; Kaper J; Hoogenveen RT; van Schayck CP; Feenstra TL
    Addiction; 2010 Jun; 105(6):1088-97. PubMed ID: 20659063
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost and effectiveness of the nationwide government-supported Smoking Cessation Clinics in the Republic of Korea.
    Oh JK; Lim MK; Yun EH; Shin SH; Park EY; Park EC
    Tob Control; 2013 May; 22(e1):e73-7. PubMed ID: 22752272
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The long-term cost-effectiveness of varenicline (12-week standard course and 12 + 12-week extended course) vs. other smoking cessation strategies in Canada.
    von Wartburg M; Raymond V; Paradis PE
    Int J Clin Pract; 2014 May; 68(5):639-46. PubMed ID: 24472120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evaluation of health benefit modification in Taft-Hartley health and welfare funds: implications for encouraging tobacco-cessation coverage.
    Au-Yeung CM; Weisman SR; Hennrikus DJ; Forster JL; Skoog R; Luneburg W; Hesse B
    Am J Prev Med; 2010 Dec; 39(6 Suppl 1):S30-6. PubMed ID: 21074675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical impact and cost-effectiveness of integrating smoking cessation into lung cancer screening: a microsimulation model.
    Evans WK; Gauvreau CL; Flanagan WM; Memon S; Yong JHE; Goffin JR; Fitzgerald NR; Wolfson M; Miller AB
    CMAJ Open; 2020; 8(3):E585-E592. PubMed ID: 32963023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking targets.
    Fitzpatrick M
    Lancet; 2003 Dec; 362(9399):1946. PubMed ID: 14667778
    [No Abstract]   [Full Text] [Related]  

  • 19. Fiscal Impact of Smoking Cessation in Thailand: A Government Perspective Cost-Benefit Analysis.
    Connolly MP; Kotsopoulos N; Suthipinijtham P; Rungruanghiranya S
    Asia Pac J Public Health; 2018 May; 30(4):342-350. PubMed ID: 29667916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Efficacy and cost-effectiveness of smoking cessation courses in the statutory health insurance: a review].
    Rasch A; Greiner W
    Gesundheitswesen; 2009 Nov; 71(11):732-8. PubMed ID: 19492280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.